Pharmaceutical patents are unusually valuable: a new molecular entity can cost about a billion dollars to develop and test, yet a blockbuster like Lipitor can sell $13-14 billion in a year, mostly profit, so without strong injunctive protection a competitor can turn $14 billion into $14 million quickly.

causalpending

Speaker

Richard Epstein

Evidence Quote

“if it really hits, say like Lipitor, you can sell 13 or 14 billion dollars of this stuff in the course of a single year”

Source

Richard Epstein on Property Rights and Drug Patents 2/19/2007— EconTalk
Created: 10/30/2026, 3:22:16 PM

Your notes

Loading notes...